Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Boehringer Ingelheim
Johnson and Johnson
Express Scripts
Harvard Business School

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020475

See Plans and Pricing

« Back to Dashboard

NDA 020475 describes RETIN-A-MICRO, which is a drug marketed by Valeant Intl and is included in one NDA. It is available from four suppliers. Additional details are available on the RETIN-A-MICRO profile page.

The generic ingredient in RETIN-A-MICRO is tretinoin. There are twenty-six drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the tretinoin profile page.
Summary for 020475
Tradename:RETIN-A-MICRO
Applicant:Valeant Intl
Ingredient:tretinoin
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020475
Medical Subject Heading (MeSH) Categories for 020475
Suppliers and Packaging for NDA: 020475
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
RETIN-A MICRO tretinoin GEL;TOPICAL 020475 NDA Bausch Health Americas Inc. 0187-5140 0187-5140-20 1 TUBE in 1 CARTON (0187-5140-20) > 20 g in 1 TUBE
RETIN-A MICRO tretinoin GEL;TOPICAL 020475 NDA Bausch Health Americas Inc. 0187-5140 0187-5140-45 1 TUBE in 1 CARTON (0187-5140-45) > 45 g in 1 TUBE
Paragraph IV (Patent) Challenges for 020475
Tradename Dosage Ingredient NDA Submissiondate
RETIN-A-MICRO GEL;TOPICAL tretinoin 020475 2010-12-20
RETIN-A MICRO GEL;TOPICAL tretinoin 020475 2010-12-20
RETIN-A MICRO GEL;TOPICAL tretinoin 020475 2010-07-08
RETIN-A-MICRO GEL;TOPICAL tretinoin 020475 2010-07-08

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:GEL;TOPICALStrength0.1%
Approval Date:Feb 7, 1997TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:GEL;TOPICALStrength0.04%
Approval Date:May 10, 2002TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:GEL;TOPICALStrength0.08%
Approval Date:Jan 28, 2014TE:RLD:Yes

Expired US Patents for NDA 020475

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Intl RETIN-A MICRO tretinoin GEL;TOPICAL 020475-002 May 10, 2002   Start Trial   Start Trial
Valeant Intl RETIN-A MICRO tretinoin GEL;TOPICAL 020475-001 Feb 7, 1997   Start Trial   Start Trial
Valeant Intl RETIN-A-MICRO tretinoin GEL;TOPICAL 020475-003 Jan 28, 2014   Start Trial   Start Trial
Valeant Intl RETIN-A MICRO tretinoin GEL;TOPICAL 020475-001 Feb 7, 1997   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
Colorcon
Mallinckrodt
Dow
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.